Stonepine Capital Management as of Sept. 30, 2023
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 23 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corp (QDEL) | 16.0 | $48M | 659k | 73.04 | |
| Evolus (EOLS) | 15.7 | $47M | 5.2M | 9.14 | |
| Amylyx Pharmaceuticals (AMLX) | 15.3 | $46M | 2.5M | 18.31 | |
| Adma Biologics (ADMA) | 10.8 | $33M | 9.1M | 3.58 | |
| Galapagos Nv- Spons Adr (GLPG) | 9.2 | $28M | 803k | 34.55 | |
| Alimera Sciences Com New (ALIM) | 4.1 | $12M | 4.0M | 3.10 | |
| Maxcyte (MXCT) | 3.9 | $12M | 3.8M | 3.12 | |
| Xeris Pharmaceuticals (XERS) | 3.7 | $11M | 5.9M | 1.86 | |
| Gamida Cell SHS (GMDA) | 2.7 | $8.2M | 8.0M | 1.03 | |
| Atyr Pharma Com New (LIFE) | 2.4 | $7.3M | 4.6M | 1.58 | |
| Scynexis Com New (SCYX) | 2.2 | $6.5M | 2.9M | 2.28 | |
| Xoma Corp Com New (XOMA) | 2.0 | $6.2M | 437k | 14.09 | |
| X4 Pharmaceuticals (XFOR) | 1.9 | $5.7M | 5.3M | 1.09 | |
| Atea Pharmaceuticals (AVIR) | 1.7 | $5.2M | 1.7M | 3.00 | |
| Rezolute Com New (RZLT) | 1.3 | $4.1M | 3.1M | 1.32 | |
| Tela Bio (TELA) | 1.3 | $3.9M | 492k | 8.00 | |
| Exagen (XGN) | 1.0 | $2.9M | 1.2M | 2.42 | |
| Io Biotech (IOBT) | 0.9 | $2.8M | 2.0M | 1.41 | |
| Gossamer Bio (GOSS) | 0.9 | $2.8M | 3.3M | 0.83 | |
| Delcath Systems Com New (DCTH) | 0.9 | $2.8M | 686k | 4.05 | |
| Assertio Holdings Com New (ASRT) | 0.8 | $2.4M | 951k | 2.56 | |
| Vanda Pharmaceuticals (VNDA) | 0.7 | $2.1M | 478k | 4.32 | |
| Aytu Biopharma (AYTU) | 0.4 | $1.3M | 472k | 2.70 |
